Molecular challenges and viral diseases.
Brown
Simon A
SA
Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK. simon.brown@royalfree.nhs.co.uk
Aledort
Louis M
LM
Lee
Christine A
CA
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D019774:Blood Coagulation Factor Inhibitors / Q000627:therapeutic use; D003226:Congresses as Topic; D007562:Creutzfeldt-Jakob Syndrome / Q000150:complications; D015316:Genetic Therapy / Q000379:methods; D006470:Hemorrhage / Q000628:therapy / Q000821:virology*; D006487:Hemostasis; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008666:Metalloendopeptidases / Q000627:therapeutic use; D011486:Protein C / Q000502:physiology; D013925:Thromboplastin / Q000627:therapeutic use; D014777:Virus Diseases / Q000150:complications*
D019774:Blood Coagulation Factor Inhibitors; D011486:Protein C; D013925:Thromboplastin; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human